We understand these are trying times and we are here to help keep your research moving forward.

As we closely monitor the situation at hand, rPeptide will remain fully operational and continue to practice all safety protocol while taking precautionary measures to ensure there are no interruptions to your research. From our catalog products to our laboratory services, please let us know how we can assist with your research needs.

Publications

ORDER ONLINE  •  CALL 866.753.0747  •  FAX 678.753.0746

Beta Amyloid Citations: 2021

Croden, J., Silva, J., et al., (2021) Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ1-42 in vitro. Plos One; https://doi.org/10.1371/journal.pone.0258208.
Domingo, G., et al. (2021) N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease. Frontiers in Neuroscience; doi: 10.3389/fnins.2021.708119.
Chandra Mouli R. Madhuranthakam, Arash Shakeri,Praveen P. N. Rao (2021) Modeling the Inhibition Kinetics of Curcumin, Orange G, and Resveratrol with Amyloid-β Peptide. ACS Omega; https://doi.org/10.1021/acsomega.1c00610.
Natarajan, K., et al (2021) Plasma metabolomics of presymptomatic PSEN1‐H163Y mutation carriers: a pilot study. Ann Clin Transl Neurol; doi: 10.1002/acn3.51296.
Stéphane L. Benoit & Robert J. Maier (2021) The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation. Scientific Reports; https://doi.org/10.1038/s41598-021-86060-1.